Naltrexone–bupropion (Mysimba) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
出版年份 2020 全文链接
标题
Naltrexone–bupropion (Mysimba) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
作者
关键词
-
出版物
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-01-10
DOI
10.1111/bcp.14210
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Benefits and Harms in Pivotal Trials of Oral Centrally Acting Antiobesity Medicines: A Systematic Review and Meta-Analysis
- (2018) Igho J. Onakpoya et al. Obesity
- Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review
- (2016) Igho J. Onakpoya et al. BMC Medicine
- Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events
- (2016) Rohan Khera et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reporting of harms outcomes: a comparison of journal publications with unpublished clinical study reports of orlistat trials
- (2016) Alex Hodkinson et al. Trials
- Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review
- (2016) Su Golder et al. PLOS MEDICINE
- Effects on cardiovascular risk factors of weight losses limited to 5–10 %
- (2015) Joshua D. Brown et al. Translational Behavioral Medicine
- Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
- (2014) Marie Ng et al. LANCET
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- Effect of combined naltrexone and bupropion therapy on the brain’s reactivity to food cues
- (2013) G-J Wang et al. INTERNATIONAL JOURNAL OF OBESITY
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- Including all individuals is not enough: Lessons for intention-to-treat analysis
- (2012) Ian R White et al. Clinical Trials
- Investigator experiences with financial conflicts of interest in clinical trials
- (2011) Paula A Rochon et al. Trials
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
- The statistical analysis of a clinical trial when a protocol amendment changed the inclusion criteria
- (2008) Christian Lösch et al. BMC Medical Research Methodology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started